ArticleBioconjugate chemistry2025

Targeted Delivery of TLR7 Agonists to the Tumor Microenvironment Enhances Tumor Immunity via Activation of Tumor-Resident Myeloid Cells.

Emanuela Sega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.